TRAIN4CHIMIO
Feasibility of EMDR (train protocol) and its impact on post-traumatic stress symptoms in patients undergoing chemotherapy for non-metastatic breast cancer: a pilot study
The primary objective of the “Train4Chimio” study is to evaluate the feasibility of the EMDR-derived “Train protocol” on trauma in patients treated with chemotherapy for non-metastatic breast cancer, as well as the impact of this intervention on their well-being and emotional regulation. A specific Eye Movement Desensitisation and Reprocessing (EMDR) therapy technique, known as the “Train Protocol”, will be used to help participants process the emotional impact of their cancer diagnosis and treatment. The study will assess whether this tailored psychological intervention can reduce symptoms of post-traumatic stress, improve emotional regulation, and enhance quality of life throughout the cancer care journey. The findings will help determine whether this approach is feasible and beneficial for people undergoing chemotherapy.

About the study
Locations
L-1210 Luxembourg
Contact
Who can participate?
Eligible participants
- Minimum age 18 years
- Current breast cancer diagnosis
- Cancer stage: non-metastatic
- Knows he/she has cancer
- Undergoing treatment with curative-intent chemotherapy
Exclusion criteria
- Suspected or confirmed psychiatric disorder in the acute phase
- Major cognitive impairment
- Consumption of more than 4 units of alcohol per day
- Drug use
- Insufficient knowledge of the French language
Not sure about eligibility?
The study team will review each case individually to determine eligibility. If you are unsure whether you are eligible, do not hesitate to contact us.

What will participants do?
01.
Attend a baseline visit
This will take place before starting chemotherapy. During this visit, the patients sign the informed consent form, answer questions about their health and medical history, and complete questionnaires about emotional well-being and quality of life.
02.
Be randomly assigned to one of two groups
Afterwards, the patients are randomly assigned to one of two groups. They will either receive the EMDR “Train Protocol” alongside with the usual psychological support during chemotherapy, or receive the usual psychological care available at the Breast Clinic without the EMDR intervention.
03.
Complete several questionnaires
These will be completed at four different time points: before the intervention (baseline), after the intervention, as well as after 3 and 6 months following the EMDR intervention (equivalent time point for the control group). Each questionnaire takes approximately 30 minutes to complete.
Contact & location

Centre Hospitalier de Luxembourg – CHL Centre
4 rue Barblé
L-1210 Luxembourg
Study team


Dr Caroline Duhem
Head Physician, Department of Hematology / Hemato-Oncology / Oncology
Centre Hospitalier de Luxembourg (CHL)Funded by
Fondation Cancer (Luxembourg)
Fondation contre le Cancer (Belgium)
Related news & updates
Small country, significant capacity
Luxembourg may be one of Europe’s smallest countries, but the Luxembourg Research Clinic demonstrates how its highly connected national network…
Building on Luxembourg’s Research Strengths
The Luxembourg Research Clinic brings together the strengths of Luxembourg’s leading healthcare, research and academic institutions, building on established expertise…
Joint action on personalised cancer medicine kicks off
Luxembourg's Research Clinic has been admitted as a full member of ECRIN, the European Clinical Research Infrastructure Network, opening access…
Related events
Clinical Research Luxembourg Conference
Why does clinical research matter today in Luxembourg? Clinical research plays a vital role in improving patient care, driving medical…